Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years

Bibliographic Details
Main Authors: Pennell, D., Porter, J.B., Cappellini, M.D., Chan, L.L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, Chi-Kong, Viprakasit, V., Elalfy, M.S., Kattamis, A., Smith, G., Habr, D., Domokos, G., Roubert, B., Taher, A.
Format: Article
Published: Amer Soc Hematology 2010
Subjects:
Online Access:http://eprints.um.edu.my/11953/
id um-11953
recordtype eprints
spelling um-119532015-01-13T06:46:07Z Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years Pennell, D. Porter, J.B. Cappellini, M.D. Chan, L.L. El-Beshlawy, A. Aydinok, Y. Ibrahim, H. Li, Chi-Kong Viprakasit, V. Elalfy, M.S. Kattamis, A. Smith, G. Habr, D. Domokos, G. Roubert, B. Taher, A. Q Science (General) R Medicine Amer Soc Hematology 2010 Article PeerReviewed Pennell, D.; Porter, J.B.; Cappellini, M.D.; Chan, L.L.; El-Beshlawy, A.; Aydinok, Y.; Ibrahim, H.; Li, Chi-Kong; Viprakasit, V.; Elalfy, M.S.; Kattamis, A.; Smith, G.; Habr, D.; Domokos, G.; Roubert, B.; Taher, A. (2010) Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years. Blood <http://eprints.um.edu.my/view/publication/Blood.html>, 116 (21). pp. 1735-1736. http://eprints.um.edu.my/11953/
repository_type Digital Repository
institution_category Local University
institution University Malaya
building UM Research Repository
collection Online Access
topic Q Science (General)
R Medicine
spellingShingle Q Science (General)
R Medicine
Pennell, D.
Porter, J.B.
Cappellini, M.D.
Chan, L.L.
El-Beshlawy, A.
Aydinok, Y.
Ibrahim, H.
Li, Chi-Kong
Viprakasit, V.
Elalfy, M.S.
Kattamis, A.
Smith, G.
Habr, D.
Domokos, G.
Roubert, B.
Taher, A.
Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years
format Article
author Pennell, D.
Porter, J.B.
Cappellini, M.D.
Chan, L.L.
El-Beshlawy, A.
Aydinok, Y.
Ibrahim, H.
Li, Chi-Kong
Viprakasit, V.
Elalfy, M.S.
Kattamis, A.
Smith, G.
Habr, D.
Domokos, G.
Roubert, B.
Taher, A.
author_facet Pennell, D.
Porter, J.B.
Cappellini, M.D.
Chan, L.L.
El-Beshlawy, A.
Aydinok, Y.
Ibrahim, H.
Li, Chi-Kong
Viprakasit, V.
Elalfy, M.S.
Kattamis, A.
Smith, G.
Habr, D.
Domokos, G.
Roubert, B.
Taher, A.
author_sort Pennell, D.
title Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years
title_short Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years
title_full Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years
title_fullStr Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years
title_full_unstemmed Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years
title_sort continued improvement and normalization of myocardial t2*in patients with beta-thalassemia major treated with deferasirox (exjade (r)) for up to 3 years
publisher Amer Soc Hematology
publishDate 2010
url http://eprints.um.edu.my/11953/
first_indexed 2018-09-06T06:02:40Z
last_indexed 2018-09-06T06:02:40Z
_version_ 1610836879955984384